This inventor holds 2 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Ogd2 Pharma, Centre National De La Recherche Scientifique, Institut De Cancerologie De L'ouest. Active years: 2022-2023.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Mickaël Terme. Retrieved from https://idiyas.com/inventor/mickaël-terme
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
USPTO Granted Patents = 2 (Patent Applications = 2)
% Patents Active = 100.0
EPO Patents = 5 (Patent Applications = 8)
Average Co-Inventor Count = 5.1
ph-index = 1
Company Filing History:
Ogd2 Pharma

Centre National De La Recherche Scientifique
Institut De Cancerologie De L'ouest
4. 1 out of 1,853

National Institute of Health and Medical Research
5. 1 out of 156

The University of Nantes
where one patent can have more than one assignee
Years Active: 2022-2023
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents pending:
IDiyas Innovation Intelligence. (2026). Inventor Profile: Mickaël Terme. Retrieved from https://idiyas.com/inventor/mickaël-terme
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
5 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
8 patents pending (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]